Literature DB >> 19683778

The mannose receptor acts as hepatitis B virus surface antigen receptor mediating interaction with intrahepatic dendritic cells.

Marjoleine L Op den Brouw1, Rekha S Binda, Teunis B H Geijtenbeek, Harry L A Janssen, Andrea M Woltman.   

Abstract

Dendritic cells (DC) play a key role in anti-viral immunity. Direct interactions between DC and hepatitis B virus (HBV) may explain the impaired DC function and the ineffective anti-viral response of chronic HBV patients resulting in HBV persistence. Here, the interaction between HBV surface antigens (HBsAg) and DC and the receptor involved were examined by flow cytometry in blood and liver tissue of HBV patients. The in vitro data showed that the mannose receptor (MR) is involved in HBsAg recognition and uptake by DC. The presence of HBsAg-positive DC was demonstrated sporadically in blood, but frequently in the liver of HBV patients. Interestingly, a positive correlation was found between HBsAg positivity and MR expression level in both liver- and blood-derived DC. These data suggest that in HBV infected patients, MR-mediated interaction between HBsAg and DC and subsequent impairment of DC predominantly occurs at the main site of infection, the liver.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19683778     DOI: 10.1016/j.virol.2009.07.015

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  23 in total

Review 1.  Dissecting the dendritic cell controversy in chronic hepatitis B virus infection.

Authors:  Adam J Gehring; June Ann D'Angelo
Journal:  Cell Mol Immunol       Date:  2014-11-03       Impact factor: 11.530

Review 2.  Imaging Macrophage-associated Inflammation.

Authors:  Catherine A Foss; Julian Sanchez-Bautista; Sanjay K Jain
Journal:  Semin Nucl Med       Date:  2018-02-13       Impact factor: 4.446

Review 3.  Targeting cardiac mast cells: pharmacological modulation of the local renin-angiotensin system.

Authors:  Alicia C Reid; Jacqueline A Brazin; Christopher Morrey; Randi B Silver; Roberto Levi
Journal:  Curr Pharm Des       Date:  2011-11       Impact factor: 3.116

4.  Design, synthesis, and biological evaluation of triazolo-pyrimidine derivatives as novel inhibitors of hepatitis B virus surface antigen (HBsAg) secretion.

Authors:  Wenquan Yu; Cally Goddard; Elizabeth Clearfield; Courtney Mills; Tong Xiao; Haitao Guo; John D Morrey; Neil E Motter; Kang Zhao; Timothy M Block; Andrea Cuconati; Xiaodong Xu
Journal:  J Med Chem       Date:  2011-08-02       Impact factor: 7.446

Review 5.  Eradication Strategies for Chronic Hepatitis B Infection.

Authors:  Eleanor M P Wilson; Lydia Tang; Shyam Kottilil
Journal:  Clin Infect Dis       Date:  2016-06-01       Impact factor: 9.079

6.  Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent Mechanism.

Authors:  Nadine van Montfoort; Evelyn van der Aa; Aniek van den Bosch; Hilde Brouwers; Thomas Vanwolleghem; Harry L A Janssen; Hassan Javanbakht; Sonja I Buschow; Andrea M Woltman
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

7.  Chronic hepatitis B: what should be the goal for new therapies?

Authors:  Timothy M Block; Robert Gish; Haitao Guo; Anand Mehta; Andrea Cuconati; W Thomas London; Ju-Tao Guo
Journal:  Antiviral Res       Date:  2013-02-04       Impact factor: 5.970

8.  MicroRNA Cargo of Extracellular Vesicles from Alcohol-exposed Monocytes Signals Naive Monocytes to Differentiate into M2 Macrophages.

Authors:  Banishree Saha; Fatemeh Momen-Heravi; Karen Kodys; Gyongyi Szabo
Journal:  J Biol Chem       Date:  2015-11-02       Impact factor: 5.157

9.  Strategies to eliminate HBV infection.

Authors:  Rama Kapoor; Shyam Kottilil
Journal:  Future Virol       Date:  2014       Impact factor: 1.831

Review 10.  Targeting the C-type lectins-mediated host-pathogen interactions with dextran.

Authors:  Sergey Pustylnikov; Divya Sagar; Pooja Jain; Zafar K Khan
Journal:  J Pharm Pharm Sci       Date:  2014       Impact factor: 2.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.